文献速递神经肿瘤神经重症

经蝶窦术后晨间皮质醇监测对下丘脑-垂体-肾上腺轴功能不全的临床价值

Clinical utility of routine postoperative morning cortisol monitoring in detecting new hypothalamic-pituitary-adrenal axis insufficiency following endoscopic transsphenoidal surgery for sellar lesions.
PubMed 文献 · J Neurosurg · 2019-03-01

该回顾性研究纳入165例行经蝶窦手术的鞍区病变患者,术后第1天晨间血清皮质醇<5 μg/dl者行第2天检测。8例(4.8%)出现术后第1天低皮质醇血症,其中6例(3.6%)确诊HPA轴功能不全并接受糖皮质激素替代,2例随访恢复,新发永久性HPA轴功能不全发生率为2.5%。作者认为在无并发症切除且保留腺体、无临床症状的患者中,常规术后皮质醇筛查可能并非必要。

要点

  • 术后第1天晨间血清皮质醇<5 μg/dl者需行第2天7 am皮质醇检测。
  • 165例中8例(4.8%)出现POD1低皮质醇血症,6例(3.6%)确诊HPA轴功能不全。
  • 新发永久性HPA轴功能不全发生率为2.5%(2/6例治疗者随访恢复)。

核心结论

  • 所有需要术后糖皮质激素替代的患者均有复杂手术过程及低皮质醇血症相关临床症状。
  • 在患者出现明确术后低皮质醇血症证据前暂不使用类固醇的方案安全且临床有效。
  • 数据提示在无并发症切除、保留腺体且无HPA轴功能障碍临床症状时,常规术后皮质醇筛查可能并非必要。

研究设计与样本

  • 回顾性综述,纳入2012至2017年南加州大学257例因垂体腺瘤或Rathke裂囊肿行经蝶窦颅骨切开术的患者。
  • 排除术前肾上腺功能不全、库欣病或术后随访不足3个月者,最终分析165例。
  • 所有患者检测术后第1天晨间血清皮质醇,<5 μg/dl者行第2天7 am皮质醇检测。

主要发现

  • 165例中女性101例(61.2%),男性64例(38.7%)。
  • 术前诊断:无功能腺瘤97例(58.7%),生长激素分泌腺瘤37例(22.4%),Rathke裂囊肿18例(10.9%),泌乳素瘤8例(4.8%),其他5例(3.0%)。
  • 术后第1天低皮质醇血症8例(4.8%),其中2例(1.2%)无症状且第2天皮质醇正常,6例(3.6%)有症状且第2天皮质醇确认HPA轴功能不全。
  • 6例接受早期糖皮质激素替代者中2例随访期间恢复HPA轴功能,新发永久性HPA轴功能不全发生率为2.5%。

关键数值与推荐

  • 术后第1天低皮质醇血症定义为血清皮质醇<5 μg/dl,触发第2天7 am皮质醇检测。
  • 两次血清皮质醇<5 μg/dl,或一次<5 μg/dl plus 高度临床怀疑HPA轴功能障碍,高危患者接受糖皮质激素补充。

临床怎么用

  • 术后第1天晨间血清皮质醇<5 μg/dl者应行第2天7 am皮质醇检测。
  • 两次皮质醇<5 μg/dl或一次<5 μg/dl plus 高度临床怀疑HPA轴功能障碍时,高危患者接受糖皮质激素补充。
  • 在无并发症切除、保留腺体且无HPA轴功能障碍临床症状时,常规术后皮质醇筛查可能并非必要。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Hypothalamic-pituitary-adrenal (HPA) axis dysfunction is a well-documented complication of transsphenoidal craniotomy (TSC) for sellar lesions. The authors aimed to assess their multidisciplinary approach to the diagnosis and treatment of postoperative hypocortisolemia utilizing conservative screening methods. METHODS: The authors performed a retrospective review of 257 patients who underwent TSC for pituitary adenoma (PA) or Rathke cleft cyst (RCC) at the University of Southern California between 2012 and 2017. Patients with preoperative adrenal insufficiency, Cushing's disease, or < 3 months of postoperative follow-up were excluded. Patient demographics, pathology, tumor characteristics, and complications were recorded. Postoperative day 1 (POD1) morning serum cortisol was assessed in all patients. Hypocortisolemia on POD1 (serum cortisol < 5 μg/dl) prompted a 7 am cortisol level measurement on POD 2 (POD2). Clinical signs and symptoms of hypocortisolemia were consistently monitored. After two serum cortisol levels < 5 μg/dl, or one serum level < 5 μg/dl plus a high clinical suspicion for HPA dysfunction, high-risk patients received glucocorticoid supplementation. RESULTS: Data on 165 patients were included in the analysis; there were 101 women (61.2%) and 64 men (38.7%). Preoperative diagnoses included nonfunctional adenoma (n = 97, 58.7%), growth hormone-secreting adenoma (n = 37, 22.4%), RCC (n = 18, 10.9%), prolactinoma (n = 8, 4.8%), and other (n = 5, 3.0%). One hundred thirty-eight patients (63.0%) had either suprasellar extension or cavernous sinus invasion. POD1 hypocortisolemia was diagnosed in 8 patients (4.8%). Of these patients, 2 (1.2%) were clinically asymptomatic and had normalized POD2 cortisol levels. Six patients (3.6%) had clinical symptoms and POD2 cortisol levels confirming HPA axis deficiency. Of these 6 patients treated with early glucocorticoid replacement, 2 patients recovered HPA axis function during follow-up, making the incidence of new, permanent HPA axis deficiency 2.5%. CONCLUSIONS: In the authors' institutional review, all patients warranting postoperative glucocorticoid replacement had both complicated surgical courses and associated clinical symptoms of hypocortisolemia. The authors' algorithm of withholding steroids until patients demonstrate clear evidence of postoperative hypocortisolemia is safe and clinically efficacious. Their data further suggest that routine postoperative cortisol screening may not be necessary following an uncomplicated operative resection, with gland preservation and the absence of clinical symptoms indicative of HPA dysfunction.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Jackanich A, Tavakol S, Strickland BA, et al. Clinical utility of routine postoperative morning cortisol monitoring in detecting new hypothalamic-pituitary-adrenal axis insufficiency following endoscopic transsphenoidal surgery for sellar lesions. J Neurosurg. 2019. PMID: 30835697. doi:10.3171/2018.11.JNS182521

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。